1. Home /
  2. Real Money Pro

Real Money Pro

Survival Tactics Are Required in This World of 'Peak Stupidity'

At some point a day of reckoning will come in a juiced-up market, but it is pure conjecture as to when that will be.

It's Hammer Time for Lululemon, but Not Yet Time to Pick Some Apple

The chart of the maker of athletic apparel has formed a technical pattern that indicates the pullback in its shares is over for now.

An All-Terrain Strategy for Portfolio Management

The market's mood seems to be changing almost daily; he's an approach for how to trade it regardless of how it's feeling on any particular day.

How to Trade the Pullback in Tesla

It's a two-step entry process that is strictly for trading purposes, not long-term investing.

2 Long-Term Bargains Emerge in Biotech

Karyopharm Therapeutics and Gamida Cell are promising companies that have seen their shares pull back significantly in recent weeks.

Is This Pullback a Buying Opportunity? Let's Check the Charts

Here's a look at the broader market via the S&P 500 and a trio of stocks that recently have pushed significantly downward.

The Stock Market Is Starting to Turn Ugly, and So Is the Labor Market

It is becoming harder for some employers to find help, in part because of generous unemployment benefits that will run into the fall.

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Dips in the shares of Redhill Biopharma and FibroGen Inc. provided the chance for the author to employ his covered call strategy.

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.

One Man's Plan for Navigating the Choppy Rising Rate Seas

Putting cash to work on significant market pullbacks such as the one that occurred Thursday is a key element of the strategy.